Favipiravir 400mgTablet
Antiviral

Favipiravir 400mg

Favipiravir

Broad-spectrum RNA-dependent RNA polymerase inhibitor that is incorporated into viral RNA as a fraudulent purine nucleotide, causing lethal mutagenesis across multiple RNA viruses. Approved in Japan for influenza and granted emergency use authorization in India and Russia for COVID-19, with Glenmark and Cipla among India's first manufacturers to supply this strategic antiviral.

Strengths

200mg / 400mg

Packing

34 tablets/pack

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Favipiravir 200mg / 400mg
Dosage Form
Tablet
Available Strengths
200mg / 400mg
Packing
34 tablets/pack
Route of Administration
Oral, with or without food
Dosage
COVID-19: 1800mg (9×200mg) twice on day 1, then 800mg (4×200mg) twice daily on days 2-14; Influenza: 1600mg twice on day 1, then 600mg twice daily
Indications
Influenza (novel or re-emerging strains), COVID-19 (mild to moderate — emergency use), Ebola (investigational)
Country of Origin
India (WHO-GMP Certified)
Storage
Store at 25°C, protected from moisture and light
Shelf Life
24 months
Side Effects
Elevated uric acid (common), nausea, diarrhea, elevated transaminases, decreased neutrophils
Precautions
Contraindicated in pregnancy (teratogenic); adequate contraception required; uric acid monitoring; avoid in gout; hepatotoxicity monitoring; limited evidence base — use under medical supervision

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Acyclovir 400mgTablet

Acyclovir 400mg

Acyclovir

First clinically successful selective antiviral and WHO Essential Medicine — a guanosine analog phosphorylated exclusively by herpes-virus thymidine kinase to specifically inhibit viral DNA polymerase. Foundational therapy for HSV and VZV infections across all age groups with a four-decade safety record in oral and intravenous formulations.

200mg / 400mg / 800mg
Valacyclovir 500mgTablet

Valacyclovir 500mg

Valacyclovir Hydrochloride

L-valyl ester prodrug of acyclovir with 3-5 times higher oral bioavailability, enabling simplified twice or three-times-daily dosing versus acyclovir's five-daily regimen. Preferred for herpes zoster management and uniquely effective as single-day therapy for herpes labialis, significantly improving patient adherence over standard acyclovir courses.

500mg / 1000mg
Oseltamivir 75mgCapsule

Oseltamivir 75mg

Oseltamivir Phosphate

Competitive neuraminidase inhibitor preventing influenza virus budding and spread from infected respiratory cells, reducing illness duration by 1-2 days when initiated within 48 hours of symptom onset. WHO pandemic stockpile antiviral recommended as first-line treatment for severe influenza in high-risk populations including the elderly, immunocompromised, and young children.

30mg / 45mg / 75mg

Need bulk pricing for Favipiravir 400mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote